Human papillomaviruses in cervical cancer I. HPV-16 and 18 predominate in the Greek population

Anticancer Research

Volumn 17, Issue 1 A, 1997, Pages 117-120

  Vassilandonopoulou, Georgia ^a   Panotopoulou, Evi ^a   Fotiou, Stelios ^a   Tserkezoglou, Aliki ^a   Machera, Eleni ^a   Kottaridis, Stavros ^a,b  

^a SAINT SAVVAS HOSPITAL   (Greece)

^b Papanikolaou Res Center of Oncology   (Greece)

Author keywords

Cervical cancer; In situ hybridization; Papillomaviruses

Indexed keywords

ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GREECE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; PAPILLOMA VIRUS; PREVALENCE; PRIORITY JOURNAL; SOUTHERN BLOTTING; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA;

FEMALE; GREECE; HUMANS; PAPILLOMAVIRIDAE; UTERINE CERVICAL NEOPLASMS;

EID: 0031049442     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. zur Hausen H: Condylomata acuminata and human genital cancer. Cancer Res 36: 530-533, 1976.
2. Ruiter M and van Mullen PJ: Demonstration by electron microscopy of an intranuclear virus in epidermodysplasia virruciformis. J Invest Dermatol 47: 247-522, 1966.
3. Durst M, Gissmann L Ikenberg H and zur Hausen H: A papillomavirus DNA from a cervical carcinomas and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 80: 3811-3815, 1983.
4. Ikenberg H, Gissmann L Gross G, Grussendorf-Cohen EJ and zur Hausen H : Human papillomavirus type-16 related DNA in genital Bowen's disease and in bowenoid papulosis. Int J Cancer 15: 563- 565, 1983.
5. zur Hausen H and Schneider A: The role of papillomaviruses in anogenital cancer In: P.M. Howley and NP Salzman (eds) The Papillomaviruses, vol 2, pp 245-263 New York: Plenum Publishing Corp, 1987.
6. Cuzick J, Terry G, Ho L: Human papillomavirus type-16 in cervical smears as a predictor of high-grade cervical intraepithelial neoplasia. Lancet 339: 959-960, 1992.
7. Southern EM: Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Molec Biol 98: 503-517, 1975.
8. Schneider A, Kraus H, Schuhmann R and Gissmann L: Papillomavirus infection of the lower genital tract: Detection of viral DNA in gynecological swabs. Int J Cancer 35: 443-448, 1985.
9. Tanaka A, Noda T, Yajima H, Hatanaka M and Ho Y: Identification of a transforming gene of human papillomavirus Type-16. J Virol 63: 1465-1419, 1989.
10. Vousden K: Interactions of human papillomavirus transforming proteins with products of tumor suppressor genes. The FASEB Journal 7: 872-879, 1993.
11. Schiffman MH: Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia. J Natl Cancer Ist 84: 394-397, 1992.
12. Fuchs PG, Girardi F and Phister H: Human papillomavirus DNA in normal metaplastic, preneoplastic and neoplastic epithelia of the cervix uteri Int J Cancer 41: 41-45, 1988.
13. Fuchs PG, Girardi F, and Pfister H: Human papillomavirus 16 DNA in cervical cancers and in lymph nodes of cervical cancer patients: a diagnostic marker for early metastasis. Int J Cancer 43: 41-44, 1989.
14. Cuzick J, Signer A and De Stavola BL: Case-control study of risk factors for cervical intraepithelial neoplasia in young women. Eur J Cancer 26: 684-690, 1990.
15. Jones CJ, Brinton LA and Hamman RF: Risk factors for In situ cervical cancer: Results from a case-control study Cancer Res 50: 3657-3662, 1990.
16. Rhim JS, Webber MM, Bello D, Lee MS, Arnstein P, Chen LS and Jay G: Stepwise immortalization and transformation of adult human prostate epithelial cells by a combination of HPV-18 and V-Ki-ras. Proc Nat Acad Sci US 91: 1187-1188, 1994.
17. von Knebel Doeberitz M, Rittmüller C, Aengeneyndt F, Jansen-Dürr P: Reversible repression of papillomavirus oncogene expression in cervival carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions. J Virol 68: 2811-2821, 1994.